To sum up, lyophilized recombinant human brain natriuretic peptide can increase the NO content in the blood of patients with acute myocardial infarction to a certain extent and effectively reduce the level of endothelin-1, which is of great significance to improve the endothelial function of patients with acute myocardial infarction. This evidence concerns the gene EDN1 and myocardial infarction.